Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?

Edgewise Therapeutics Ownership Summary

Edgewise Therapeutics is owned by 110.67% institutional investors, 0.53% insiders. Orbimed advisors is the largest institutional shareholder, holding 16.01% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.74% of its assets in Edgewise Therapeutics shares.

EWTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edgewise Therapeutics	110.67%	0.53%	-11.20%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	15.02M	16.01%	$401.08M
Ra capital management	8.91M	9.50%	$237.87M
Blackrock funding, inc. /de	6.48M	6.91%	$172.99M
Blackrock	6.02M	6.87%	$108.34M
Baker bros. advisors lp	6.16M	6.56%	$164.36M
Novo	5.00M	5.33%	$133.50M
Janus henderson group	4.98M	5.31%	$133.04M
Paradigm biocapital advisors lp	4.49M	4.79%	$119.99M
Vanguard group	4.47M	4.76%	$119.26M
Cormorant asset management, lp	3.41M	3.63%	$90.95M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.03M	36.77%	$27.51M
Orbimed advisors	15.02M	8.28%	$401.08M
Novo	5.00M	8.08%	$133.50M
Foresite capital management vi	585.00K	6.96%	$15.62M
Cormorant asset management, lp	3.41M	5.00%	$90.95M
Paradigm biocapital advisors lp	4.49M	4.17%	$119.99M
Bioimpact capital	1.08M	4.09%	$28.82M
Ra capital management	8.91M	3.17%	$237.87M
Acuta capital partners	87.66K	2.35%	$2.34M
Opaleye management	480.00K	2.24%	$12.82M

Top Buyers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	4.49M	4.17%	1.70M
Blackrock	6.02M	0.00%	848.71K
First light asset management	780.64K	1.99%	780.64K
Foresite capital management vi	585.00K	6.96%	585.00K
Integral health asset management	550.00K	1.25%	550.00K

Top Sellers

Holder	Shares	% Assets	Change
Tcg crossover management	-	-	-2.11M
Frazier life sciences management	-	-	-1.27M
Ecor1 capital	-	-	-1.25M
Vr adviser	-	-	-1.00M
Novo	5.00M	8.08%	-549.90K

New Positions

Holder	Shares	% Assets	Change	Value
First light asset management	780.64K	1.99%	780.64K	$20.84M
Foresite capital management vi	585.00K	6.96%	585.00K	$15.62M
Integral health asset management	550.00K	1.25%	550.00K	$14.69M
Pictet asset management sa	301.24K	0.01%	301.24K	$8.04M
Tang capital management	300.00K	0.53%	300.00K	$8.01M

Sold Out

Holder	Change
National bank of canada /fi/	-3.00
Pnc financial services group	-4.00
Creekmur asset management	-8.00
Nelson, van denburg & campbell wealth management group	-8.00
Newedge advisors	-9.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	214	1.42%	105,276,596	6.36%	110	0.99%	104	-14.05%	63	5.00%
Dec 31, 2024	67	-64.55%	17,838,374	-82.39%	19	0.16%	35	-68.75%	20	-53.49%
Sep 30, 2024	188	33.33%	101,300,175	-0.31%	107	0.80%	112	23.08%	43	48.28%
Jun 30, 2024	141	9.30%	101,619,838	10.90%	116	1.06%	91	1.11%	29	3.57%
Mar 31, 2024	129	9.32%	91,633,567	15.05%	104	0.67%	90	11.11%	28	40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.89M	2.74%	338.82K
Vanguard US Total Market Shares ETF	2.54M	2.67%	-5.23K
iShares Russell 2000 ETF	1.89M	1.80%	927.00
BB Biotech AG Ord	1.43M	1.51%	-
Fidelity Small Cap Growth	983.35K	1.05%	-284.60K
Vanguard Institutional Extnd Mkt Idx Tr	1.07M	1.01%	151.14K
Polar Capital Biotech S Inc	1.00M	0.95%	750.00K
Fidelity Small Cap Index	720.01K	0.68%	4.13K
Artisan International Small-Mid Investor	632.96K	0.66%	-76.45K
Artisan Non-U.S. Small-Mid Growth Comp	632.96K	0.66%	-76.45K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 02, 2025	Russell Alan J	Chief Scientific Officer	Sell	$25.52K
May 02, 2025	MOORE JOHN R	General Counsel	Sell	$31.76K
May 02, 2025	KOCH KEVIN	President and CEO	Sell	$70.36K
May 02, 2025	Donovan Joanne M.	CMO	Sell	$85.35K
May 02, 2025	Derakhshan Behrad	Chief Business Officer	Sell	$27.82K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	8
2024 Q4	-	3
2024 Q3	-	10
2024 Q2	-	6

EWTX Ownership FAQ

Who Owns Edgewise Therapeutics?

Edgewise Therapeutics shareholders are primarily institutional investors at 110.67%, followed by 0.53% insiders and -11.20% retail investors. The average institutional ownership in Edgewise Therapeutics's industry, Biotech Stocks , is 63.96%, which Edgewise Therapeutics exceeds.

Who owns the most shares of Edgewise Therapeutics?

Edgewise Therapeutics’s largest shareholders are Orbimed advisors (15.02M shares, 16.01%), Ra capital management (8.91M shares, 9.50%), and Blackrock funding, inc. /de (6.48M shares, 6.91%). Together, they hold 32.42% of Edgewise Therapeutics’s total shares outstanding.

Does Blackrock own Edgewise Therapeutics?

Yes, BlackRock owns 6.87% of Edgewise Therapeutics, totaling 6.02M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 108.34M$. In the last quarter, BlackRock increased its holdings by 848.7K shares, a 16.43% change.

Who is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested, with 36.77% of its assets in 1.03M Edgewise Therapeutics shares, valued at 27.51M$.

Who is the top mutual fund holder of Edgewise Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Edgewise Therapeutics shares, with 2.74% of its total shares outstanding invested in 2.89M Edgewise Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools